ADYEN Stock Was Up By 22.03% Today

(VIANEWS) – The Market ended the session with ADYEN (ADYEN.AS) jumping 22.03% to €1,444.40 on Thursday while AEX-Index jumped 1.64% to €843.75. ADYEN’s last close was €1,183.60, 30.34% below its 52-week high of €1,699.20. About ADYEN Adyen N.V. operates a payments platform in Europe, the Middle East, Africa, North America, the Asia Pacific, Latin America….

Read More

AERKOMM Stock Soars 26% In 5 Sessions: Is This The Start Of A Bullish Trend?

(VIANEWS) – AERKOMM INC (CAC 40: AKOM.PA) shares have seen an extraordinary surge of 26.13 per cent over five trading sessions, increasing from EUR2.22 to EUR2.80 at 14:47 EST on Thursday afternoon – this following three straight losses. Meanwhile, CAC 40 index is up 0.63% at EUR7,658.94 following previous session’s downward trend. About AERKOMM INC…

Read More

ADYEN Stock Soars 22%: Is This The Start Of A Bullish Run?

(VIANEWS) – At 14:06 EST on Thursday, shares of ADYEN (AEX-Index: ADYEN.AS) surged 22.03% to EUR1,444.40 following three consecutive trading sessions of decline. Furthermore, the AEX-Index advanced by 1.39% to EUR841.71, following its downward trend during Wednesday’s session; suggesting a broad upward trend today in trading activity. ADYEN closed at EUR1,183.60 on November 25, 30.34%…

Read More

NORTHERN DRILLING Stock Impressive Jump On Wednesday, Outperforms Market

(VIANEWS) – The Market ended the session with NORTHERN DRILLING (NODL.OL) jumping 17.15% to kr0.53 on Wednesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI fell 2.05% to kr1,247.17, following the last session’s upward trend on what was an all-around bearish trend exchanging session today. NORTHERN DRILLING’s last close was kr0.45, 98.71% under…

Read More

BERGENBIO Stock Was Up By 12.18% Today

(VIANEWS) – The Market ended the session with BERGENBIO (BGBIO.OL) rising 12.18% to kr0.30 on Wednesday while Oslo Børs Benchmark Index_GI dropped 2.05% to kr1,247.17. BERGENBIO’s last close was kr0.27, 97.92% under its 52-week high of kr13.03. About BERGENBIO BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug…

Read More